FFAR2 and psoriasis: AHR expression significantly increase in the serum and skin lesions of patients with AD (Kim et al., 2014; Beránek et al., 2018; Hu et al., 2020), whereas PPARγ, GPR43, and GPR109a downregulate in psoriasis (Lin et al., 2022).